Anti-MMP-3 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the hinge region of human MMP-3 (Stromelysin-1), validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Mouse, Pan, Monkey, Dog, Cat
UniProt
P08254
Size
100ug
Cat. #
RP2MMP3

In stock

SKU
RP-MMP3

Options

As low as: $130.00

Target Overview

Matrix metalloproteinase-3 (MMP-3, EC 3.4.24.17), also known as Stromelysin-1, is a secreted zinc-dependent endopeptidase that degrades extracellular matrix (ECM) components including fibronectin, laminin, collagens III, IV, IX, and X, and cartilage proteoglycans. MMP-3 is synthesized as a 477-amino acid zymogen (UniProt P08254) and activated in the ECM by the plasmin signaling cascade. Beyond its classical role in matrix remodeling, MMP-3 activates other proteases (including MMP-9) and growth factors, and possesses intracellular functions. In dopaminergic neurons under stress conditions, MMP-3 is activated by HTRA2 and mediates neuronal degeneration through microglial activation and alpha-synuclein cleavage. Recent evidence demonstrates nuclear translocation upon viral infection, where it modulates NF-kappa-B signaling and exhibits antiviral activity against vesicular stomatitis virus, influenza A (H1N1), and herpes simplex virus 1. Researchers study MMP-3 in osteoarthritis, rheumatoid arthritis, cancer metastasis, neurodegeneration, and wound healing models.

Background

MMP-3 belongs to the matrix metalloproteinase family of zinc-dependent endopeptidases responsible for ECM turnover during tissue remodeling, development, and inflammation. The enzyme exhibits broad substrate specificity, cleaving not only structural matrix proteins but also non-matrix substrates that regulate immune response and cellular signaling. Its ability to activate pro-MMP-9 and other latent MMPs positions MMP-3 as a key upstream regulator in proteolytic cascades. The hinge region targeted by this polyclonal antibody series connects the catalytic and hemopexin domains and is accessible in both latent and active forms of the enzyme. MMP-3 expression is upregulated in osteoarthritis, where cartilage degradation correlates with elevated synovial fluid levels of the protease. Recent animal studies have explored MMP-3 as a therapeutic target: Sun et al. (2026) demonstrated that polysaccharide intervention in a mouse osteoarthritis model modulated MMP-3 expression alongside cartilage-protective effects, while Takahata et al. (2026) identified protective microRNA signatures in synovial fluid that correlate inversely with MMP-3 activity in acute synovitis-driven osteoarthritis. The enzyme is also implicated in preterm labor, where inflammatory signatures including MMP-3 contribute to cervical remodeling and membrane weakening. Triple Point Biologics offers five MMP-3 antibody products, including four rabbit polyclonal clones and one monoclonal option, all raised against the hinge region. Reactivity has been validated in human samples and cross-reactivity is predicted for mouse, primate, canine, and feline tissues based on sequence conservation. Applications include Western blot, immunohistochemistry, and immunofluorescence.

References

  1. Sun HL et al (2026) Evaluating the Therapeutic Potential of Hyriopsis cumingii Polysaccharide in Osteoarthritis: Insights from a Mouse Model. Rejuvenation Res. PubMed · doi:10.1177/15491684251414069
  2. Takahata K et al (2026) Novel Biomaterial-Based Synovial Fluid Analysis Reveals Protective microRNA Signatures in a Mouse Model of Acute Synovitis-Driven Osteoarthritis. FASEB J. PubMed · doi:10.1096/fj.202505006R
  3. Hong S et al (2026) Vaginal dysbiosis and inflammatory signatures in preterm labor: an integrated model for predicting preterm birth. Front Immunol. PubMed · doi:10.3389/fimmu.2026.1809046

Additional Specifications

Gene Symbol MMP3
UniProt ID P08254
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Mouse, Pan, Monkey, Dog, Cat
Pack Size 100ug
Immunogen (Full-length recombinant human protein)Full-length recombinant human MMP-3 protein. Immunogen is proprietary and confidential.
Immunogen (Hinge region)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 262-287.
Immunogen (Carboxyterminal end)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 427-477.
Immunogen (Â Aminoterminal end of active enzyme)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 100-150.
Immunogen (Propeptide region)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 18-99.
Alternate Names Stromelysin-1, SL-1, Matrix metalloproteinase-3, MMP-3, Transin-1, EC 3.4.24.17

Frequently Asked Questions

What molecular weight band should I expect for MMP-3 on Western blot?

MMP-3 is synthesized as a 57 kDa pro-enzyme (stromelysin-1 zymogen) comprising 477 amino acids. Upon activation in the extracellular matrix, proteolytic cleavage removes the N-terminal pro-domain, yielding the active form at approximately 45 kDa. In most cell lysates and conditioned media, you will detect both the pro-form and active form, depending on cellular activation state. Serum-starved fibroblasts or stimulated chondrocytes typically show enrichment of the zymogen, while samples treated with plasmin or organomercurial compounds favor the processed form. Always run a positive control lysate from stimulated cells to confirm band identity.

Does this antibody detect mouse MMP-3 or only human MMP-3?

This polyclonal antibody is validated for human MMP-3. Mouse reactivity is predicted but not yet validated in our hands. Human and mouse MMP-3 share approximately 82 percent sequence identity, with conservation highest in the catalytic domain. If working with mouse samples, we recommend testing at the standard 1:1000 dilution first, using recombinant mouse MMP-3 or lysate from LPS-stimulated mouse macrophages as positive controls. Include a human control in parallel to confirm specificity. Report your results; cross-species validation depends on epitope accessibility and post-translational context.

What is the recommended starting dilution for Western blot with this MMP-3 antibody?

Start at 1:1000 dilution in 5 percent non-fat milk or BSA in TBST for Western blot. This dilution is optimized for standard chemiluminescent detection with 20–40 micrograms total protein per lane. MMP-3 is a secreted protease, so conditioned media often yields stronger signal than whole-cell lysate; concentrate serum-free media 10- to 20-fold if needed. For low-abundance samples or short exposures, titrate upward to 1:500. Overnight incubation at 4 degrees Celsius typically improves sensitivity compared to one-hour room-temperature protocols. Always include a recombinant MMP-3 standard or known positive lysate.

Can this antibody distinguish between pro-MMP-3 and active MMP-3?

This antibody recognizes both the 57 kDa pro-enzyme and the 45 kDa active form, as the epitope spans a region retained after N-terminal cleavage. You will detect both forms on Western blot if they are present in your sample. To assess activation status, run reducing SDS-PAGE and quantify the ratio of the two bands. For functional assays requiring selective detection of active MMP-3, consider activation-state-specific antibodies or enzymatic assays. Most cell culture supernatants contain predominantly pro-MMP-3 unless exogenous activators such as trypsin, plasmin, or APMA are added.

What positive control samples work best for detecting MMP-3?

Human fibroblasts or chondrocytes stimulated with IL-1 beta or TNF-alpha for 24 to 48 hours robustly express MMP-3 in conditioned medium. HT-1080 fibrosarcoma cells constitutively secrete moderate levels. For tissue lysates, use arthritic cartilage, inflamed synovium, or wound-edge skin, where MMP-3 is upregulated during matrix remodeling. Recombinant human MMP-3 provides a defined standard; load 5 to 10 nanograms per lane. Avoid heavily serum-supplemented media as controls, since serum proteases can degrade or activate MMP-3, complicating interpretation. Always process positive controls in parallel with experimental samples.

Does MMP-3 require special sample preparation to prevent degradation or autoactivation?

Yes. MMP-3 is both a protease and a substrate for other MMPs, so rapid processing is critical. Lyse cells on ice in buffer containing protease inhibitor cocktail with EDTA or EGTA to chelate zinc and calcium, preventing autocatalytic activation. For conditioned media, add inhibitors immediately upon collection and store at minus 80 degrees Celsius in single-use aliquots. Avoid repeated freeze-thaw cycles, which can induce aggregation or cleavage. If studying MMP-3 activation, omit metalloproteinase inhibitors but work quickly and include time-zero controls to document baseline zymogen levels before induced processing occurs.

Can I use this antibody for immunohistochemistry on paraffin-embedded tissue?

Our antibodies are validated for IHC applications, including paraffin sections. For MMP-3, antigen retrieval is essential; citrate buffer pH 6.0 heat-induced epitope retrieval for 20 minutes typically works well. MMP-3 localizes to stromal fibroblasts, chondrocytes, and activated macrophages in inflamed or remodeling tissues, with occasional nuclear staining in virus-infected or stressed cells. Use 1:100 to 1:200 dilution as a starting point. Synovium from rheumatoid arthritis patients or healing wound tissue serve as informative positive controls. Include isotype-matched control IgG on serial sections to confirm specificity of stromal staining.

How should I store this MMP-3 antibody for long-term stability?

Store the antibody at minus 20 degrees Celsius in the supplied buffer. For extended stability beyond six months, aliquot into small volumes immediately upon receipt to minimize freeze-thaw cycles, which can reduce titer and increase aggregation. Avoid repeated thawing; each working aliquot tolerates up to three freeze-thaw cycles without significant loss of reactivity. If using frequently, prepare a working stock diluted 1:10 in PBS with 50 percent glycerol and 0.02 percent sodium azide; this remains stable at minus 20 degrees Celsius for at least 12 months. Do not store diluted antibody in TBST without preservative.

Western blot validation for RP-MMP3 — 1 panel across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

MMP-3: Carboxyterminal end — WB validation
WB · Panel 1 MMP-3: Carboxyterminal end

Custom validation studies available on request — contact us.

Also known as:

  • Stromelysin-1
  • SL-1
  • Matrix metalloproteinase-3
  • MMP-3
  • Transin-1
  • EC 3.4.24.17
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →